A - NYSE
Agilent Technologies, Inc.
$137.40
+0.99%Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide. It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.
At a Glance
Live SnapshotAgilent Technologies, Inc. Management Team
Mr. Padraig McDonnell
Chief Executive Officer, President & Director
Compensation
$1,560,585
Mr. Rodney Gonsalves
Interim Chief Financial Officer, Principal Accounting Officer, Vice President & Corporate Controller
Ms. Yvonne Mackie
MD of UK & Ireland Operations and Vice President of Human Resources - Europe
Mr. Rodney Gonsalves
Principal Accounting Officer, Vice President & Corporate Controller
Dr. Simon May
SVice President & President of LDG
Compensation
$882,855
Mr. Frederick Schwarz
SVice President, Chief Strategy & Corporate Development Officer
Mr. Robert W. McMahon C.M.A.
Senior Vice President & Chief Financial Officer
Compensation
$1,165,278
Ms. Meghan A. Henson
Senior Vice President & Chief Human Resources Officer
Mr. August Specht Ph.D.
Senior Vice President & Chief Technology Officer
Mr. Henrick Ancher-Jensen
Senior Vice President and President of Order Fulfillment & Supply Chain
Compensation
$990,759
Mr. Bret M. DiMarco
Senior Vice President, Chief Legal Officer, & Secretary
Ms. Jenipher E. Dalton
Senior Vice President, Chief Quality & Regulatory Officer
Agilent Technologies, Inc. Insider Positioning
During the last 12 months, insiders have sold $3.73M worth of A shares, with no buying activity reported.
3 Months
0
0.00
1.6K
216.67K
-217K
-$217K
3-6 Months
0
0.00
0
0.00
+0
+$0
6-9 Months
0
0.00
19.0K
2.86M
-2.9M
-$2.86M
9-12 Months
0
0.00
5.5K
654.57K
-655K
-$655K
Top Buyers
No buying activity
Top Sellers
Mcdonnell Padraig
Director, Officer: President And Ceo
$2.66M
Dolsten Mikael
Director
$606K
Gonsalves Rodney
Officer: V.P., Corporate Controller
$465K
Brown Judy L
Director
$815
Insider Activity Analysis
Net Insider Sentiment
Strong bearish signal with $3.73M net selling. Heavy insider selling may indicate concerns about valuation or near-term prospects.
Buy/Sell Ratio
Very poor ratio. Heavy selling with minimal buying suggests insiders may be concerned about valuation or outlook.
Recent Trend (3 Months)
Heavy recent selling activity. Recent insider sales notably exceed purchases—may warrant investigation into company developments.
Insider Participation
4 insider sellers vs. 0 buyers. Widespread selling across multiple insiders may signal concerns.
Insider Activity Insight
Multiple red flags: Heavy selling, numerous sellers, and continued recent selling create a concerning pattern. Investigate fundamental drivers and consider whether company guidance or industry conditions have deteriorated.
SEC Filings
A - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2026 N/A | February 06, 2026 | March 18, 2026 | 2026 | |
DEF 14A DEF 14A 2025 N/A | January 31, 2025 | March 13, 2025 | 2025 | |
DEF 14A DEF 14A 2024 N/A | February 02, 2024 | March 14, 2024 | 2024 | |
DEF 14A DEF 14A 2023 N/A | February 03, 2023 | March 15, 2023 | 2023 | |
DEF 14A DEF 14A 2022 N/A | February 03, 2022 | March 16, 2022 | 2022 | |
DEF 14A DEF 14A 2021 N/A | February 04, 2021 | March 17, 2021 | 2021 | |
DEF 14A DEF 14A 2020 N/A | February 06, 2020 | March 18, 2020 | 2020 | |
DEF 14A DEF 14A 2019 N/A | February 07, 2019 | March 20, 2019 | 2019 | |
DEF 14A DEF 14A 2018 N/A | February 08, 2018 | March 21, 2018 | 2018 | |
DEF 14A DEF 14A 2017 N/A | February 02, 2017 | March 15, 2017 | 2017 |
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.